Adria D. Mathis

ORCID: 0000-0002-1119-095X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Virology and Viral Diseases
  • COVID-19 epidemiological studies
  • Vaccine Coverage and Hesitancy
  • Respiratory viral infections research
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • SARS-CoV-2 and COVID-19 Research
  • Parvovirus B19 Infection Studies
  • Immune responses and vaccinations
  • Migration, Health and Trauma

Centers for Disease Control and Prevention
2021-2025

National Center for Immunization and Respiratory Diseases
2021-2025

AID Atlanta
2024

Holloman Air Force Base
2022

Measles is a highly infectious febrile rash illness and was declared eliminated in the United States 2000.However, measles importations continue to occur, U.S. elimination status threatened 2019 as result of two prolonged outbreaks among undervaccinated communities New York City.To assess after provide context understand more recent increases cases, CDC analyzed epidemiologic laboratory surveillance data performance system these outbreaks.During January 1, 2020-March 28, 2024, notified 338...

10.15585/mmwr.mm7314a1 article EN MMWR Morbidity and Mortality Weekly Report 2024-04-11

A multistate measles outbreak, predominantly affecting members of close-knit communities with low vaccination coverage in New Mexico, Oklahoma, and Texas began January 2025. As April 17, a total 800 cases have been reported the United States 2025; 654 (82%) associated ongoing outbreak. These represent an approximately 180% increase over 285 during all 2024, second highest annual case count 25 years. Overall, 771 (96%) patients unvaccinated or had unknown status (77% were unvaccinated, 14%...

10.15585/mmwr.mm7414a1 article EN MMWR Morbidity and Mortality Weekly Report 2025-04-24

Syndromic polymerase chain reaction (PCR) panels are used to test for pathogens that can cause rash illnesses, including measles.Rash illnesses have infectious and noninfectious causes, approximately 5% of persons experience a 7-10 days after receipt measles, mumps, rubella (MMR) vaccine.MMR vaccine includes live attenuated measles virus, which is detectable by PCR tests.No evidence exists person-to-person transmission illness does not typically result among immunocompetent persons.During...

10.15585/mmwr.mm7312a3 article EN MMWR Morbidity and Mortality Weekly Report 2024-03-28

On Aug 29, 2021, Operation Allies Welcome (OAW) was established to support the resettlement of more than 80 000 Afghan evacuees in USA. After identification measles among evacuees, incoming evacuee flights were temporarily paused, and mass vaccination aged 6 months or older introduced domestically overseas, with a 21-day quarantine period after vaccination. We aimed evaluate patterns virus transmission during this outbreak impact control measures.

10.1016/s2468-2667(23)00130-5 article EN cc-by-nc-nd The Lancet Public Health 2023-07-27

Measles elimination (interruption of endemic measles virus transmission) in the United States was declared 2000; however, number cases and outbreaks have increased recent years. We characterized epidemiology transmission patterns after to identify potential gaps US control program.

10.1093/cid/ciab979 article EN public-domain Clinical Infectious Diseases 2021-11-22

Abstract Background Despite high vaccine-effectiveness, wild-type measles can occur in previously vaccinated persons. We compared the clinical presentation and disease severity of by vaccination status age post-elimination era United States. Methods included U.S. cases reported from 2001–2022. Breakthrough was defined as with ≥1 documented dose measles-containing vaccine, classic presence rash, fever, symptoms (cough, coryza, or conjunctivitis), severe pneumonia, encephalitis,...

10.1093/cid/ciae470 article EN Clinical Infectious Diseases 2024-09-13
Nina B. Masters Adria D. Mathis Jessica Leung Kelley Raines Nakia Clemmons and 95 more Kathryn Miele S. Arunmozhi Balajee Tatiana M. Lanzieri Mona Marin Deborah Christensen Kevin R. Clarke Miguel A. Cruz Kathleen Gallagher Shannon Gearhart Alida M. Gertz Onalee Grady-Erickson Caroline Habrun Gimin Kim Michael H. Kinzer Shanna Miko M. Steven Oberste Julia K. Petras Emily G. Pieracci Ian W. Pray Hannah G. Rosenblum James Ross Erin Rothney Hannah E. Segaloff Leah Shepersky Kimberly A. Skrobarcek Anna Stadelman Kelsey M. Sumner Michelle A. Waltenburg Michelle Weinberg Mary Claire Worrell Noelle E. Bessette Lilian R. Peake Marshall P. Vogt Meredith Robinson Ryan P. Westergaard Richard Griesser Joseph P. Icenogle Stephen N. Crooke Bettina Bankamp Scott E. Stanley Paul Friedrichs Larry D. Fletcher Iván A. Zapata Herbert O. Wolfe Pritesh H. Gandhi Julia Y. Charles Clive Brown Martín S. Cetron Nicki Pesik Nancy Knight Francisco Alvarado‐Ramy Michael J. Bell Leisel Talley Lisa D. Rotz Paul A. Rota David E. Sugerman Paul A. Gastañaduy Indu B. Ahluwalia Olubunmi Akinkugbe Aaron Aranas Melissa Arons Christine Atherstone Valerie Bampoe Patricia A. Bessler Leticia Bligh Kimberly Bonner Virginia B. Bowen Kendra Broadwater Gary W. Brunette Joan Brunkard Dru A. Burns Molly E. Cantrell Bryan Christensen James R. Cope Janine Cory Nathan E. Crawford David Daigle Scott Daly Peter M. DeJonge Mushtaq Dualeh Kevin Dunn Rachel B. Eidex Kai Elgethun Geroncio Fajardo Maureen Fonseca‐Ford Katherine A. Franc Joanna Gaines Nisha George James L. Goodson Caitlin Green Aaron J. Grober Kibrten Hailu Duane Hammond Brian H. Harcourt A.P. Hess

§ Hotel A is located in Virginia and was closed to the public used only for quarantine isolation during OAW.¶ November 26 42 days, or two maximum incubation periods, after rash onset last case (October 15); a measles outbreak considered have ended if there are no additional outbreak-related cases more periods under continued surveillance.** https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/sur veillance/monitoring/...

10.15585/mmwr.mm7117a2 article EN MMWR Morbidity and Mortality Weekly Report 2022-04-28

Measles and rubella are vaccine-preventable viral diseases can be prevented by safe, highly effective vaccination with measles- rubella-containing vaccines. Given the myriad causes of febrile exanthems, laboratory surveillance for both measles is important to document incidence these track progress maintenance elimination in near- post-elimination settings. Diagnostic challenges hinder classification efforts demonstrate achievement or elimination. In this report, we review diagnostic

10.3390/vaccines12060697 article EN cc-by Vaccines 2024-06-20
Coming Soon ...